The importance of metabolic and proteomic analyses in identifying treatment pathways for cancer patients
Sep 11, 2023 ·
43m 11s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Listen in as the CEO of TD2, Dr. Stephen Gately, sits down with Dr. Ed Weinstein, co-founder and CEO of Panome Bio, to discuss their important research on metabolomics and...
show more
Listen in as the CEO of TD2, Dr. Stephen Gately, sits down with Dr. Ed Weinstein, co-founder and CEO of Panome Bio, to discuss their important research on metabolomics and proteomics. Gain insights into new screening technology for important metabolic and proteomic changes that occur in response to new drugs in development for cancer patients.
show less
Information
| Author | Industry Dive's studioID |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
